Dr. Martens (LON:DOCS) Hits New 12-Month Low at $54.40

Dr. Martens plc (LON:DOCS) reached a new 52-week low during trading on Friday . The stock traded as low as GBX 54.40 ($0.72) and last traded at GBX 56 ($0.74), with a volume of 30296453 shares changing hands. The stock had previously closed at GBX 64.10 ($0.85).

Dr. Martens Price Performance

The stock has a market cap of £496.73 million, a P/E ratio of 737.86, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. The business’s 50-day simple moving average is GBX 69.23 and its two-hundred day simple moving average is GBX 78.09.

Insider Buying and Selling

In related news, insider Lynne Weedall purchased 25,000 shares of Dr. Martens stock in a transaction dated Tuesday, August 27th. The stock was bought at an average cost of GBX 74 ($0.98) per share, for a total transaction of £18,500 ($24,438.57). In the last ninety days, insiders acquired 25,426 shares of company stock valued at $1,880,142. Company insiders own 4.36% of the company’s stock.

Dr. Martens Company Profile

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.